BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8776356)

  • 1. Langerhans cell histiocytosis--clinicopathological reappraisal and human leucocyte antigen association.
    Yu RC; Chu AC
    Br J Dermatol; 1996 Jul; 135(1):36-41. PubMed ID: 8776356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic heterogeneity in single-system and multisystem langerhans cell histiocytosis.
    Bernstrand C; Carstensen H; Jakobsen B; Svejgaard A; Henter JI; Olerup O
    Pediatr Res; 2003 Jul; 54(1):30-6. PubMed ID: 12700369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis.
    Amir G; Weintraub M
    Pediatr Blood Cancer; 2008 Feb; 50(2):304-7. PubMed ID: 17455317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
    Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
    Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis.
    Bernstrand C; Cederlund K; Sandstedt B; Ahström L; Lundell M; Dahlquist G; Henter JI
    Med Pediatr Oncol; 2001 Apr; 36(4):459-68. PubMed ID: 11260569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and diagnosis of langerhans cell hyperplasia].
    Zhang K; Zeng H; Chen WQ
    Ai Zheng; 2006 Jan; 25(1):88-91. PubMed ID: 16405758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of macrophage markers in childhood and adult Langerhans histiocytosis (LCH)].
    Köhalmi F; Strausz J; Egerváry M; Szekeres G; Tímár J
    Orv Hetil; 1997 Jun; 138(22):1399-402. PubMed ID: 9254359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter.
    McClain KL; Laud P; Wu WS; Pollack MS
    Med Pediatr Oncol; 2003 Dec; 41(6):502-7. PubMed ID: 14595706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cell histiocytosis: retrospective analysis of 217 cases in a single center.
    Yağci B; Varan A; Cağlar M; Söylemezoğlu F; Sungur A; Orhan D; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    Pediatr Hematol Oncol; 2008 Jun; 25(5):399-408. PubMed ID: 18569842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in histiocytosis X.
    Lahey ME
    Am J Pediatr Hematol Oncol; 1981; 3(1):57-60. PubMed ID: 6972178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Langerhans cell histiocytosis in children.
    Grifo AH
    J Pediatr Oncol Nurs; 2009; 26(1):41-7. PubMed ID: 18936291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998.
    Alston RD; Tatevossian RG; McNally RJ; Kelsey A; Birch JM; Eden TO
    Pediatr Blood Cancer; 2007 May; 48(5):555-60. PubMed ID: 16652350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome in children with Langerhans cell histiocytosis.
    Jubran RF; Marachelian A; Dorey F; Malogolowkin M
    Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in histiocytosis X].
    Benz-Lemoine E
    Ann Pediatr (Paris); 1989 Oct; 36(8):499-503. PubMed ID: 2683947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver involvement in Langerhans' cell histiocytosis: a study of nine cases.
    Kaplan KJ; Goodman ZD; Ishak KG
    Mod Pathol; 1999 Apr; 12(4):370-8. PubMed ID: 10229501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans' cell histiocytosis: paediatric head and neck study.
    al-Ammar AY; Tewfik TL; Bond M; Schloss MD
    J Otolaryngol; 1999 Oct; 28(5):266-72. PubMed ID: 10579156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases.
    Edelweiss M; Medeiros LJ; Suster S; Moran CA
    Hum Pathol; 2007 Oct; 38(10):1463-9. PubMed ID: 17669469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
    Davidson L; McComb JG; Bowen I; Krieger MD
    J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.